News

“Cushing Syndrome is a life-changing disease that's frequently missed in traditional evaluations,” said Dr. Tobias Carling, endocrine surgeon and founder of the Carling Adrenal ...
Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...
Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...
The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...
There are many people with online courses and cure-all products to sell you to help with stress. That said, is "cortisol ...
Andy and Anna Mignery share their health journey by providing clean eating choices at The Thrivery in Center Point.
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
Type 2 diabetes is a global health concern, especially in low- and middle-income countries, where its prevalence is rapidly increasing ...
Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by ...
Salivary cortisol measurements are particularly useful to investigate cyclical Cushing's syndrome. At least partial autonomy of cortisol production (either direct from the adrenal cortex or ...